Introduction
============

Epiphysis is the terminal section of a growing long bone in mammals. It is separated from the bone shaft (diaphysis) by cartilage. New bone is produced on the side of the cartilage facing the diaphysis, while new cartilage is produced on the other side of the cartilage plate. At the joint, the epiphysis is covered with articular cartilage and a zone of subchondral bone is located below articular cartilage. In young animals, the epiphyses of long bones grow by chondrogenesis within the articular cartilage. A better understanding of the molecular mechanisms that regulate the growth of articular cartilage may give insight into the antecedents of joint disease, such as osteonecrosis [@B1], [@B2].

Canonical Wnt/β-catenin signaling plays a critical role in skeletal development and postnatal bone growth [@B3]-[@B7]. During skeletal development, activation of β-catenin signaling in limb mesenchymal cells inhibits cartilage development and promotes osteoblast differentiation [@B3], [@B4]. β-catenin also induces growth plate chondrocyte differentiation [@B5]. In mature osteoblasts, β-catenin promotes osteoblast differentiation and inhibits osteoclast formation [@B6]. Our previous studies indicate that β-catenin expressed in *Col2*-expressing cells interacts with osteoclast precursor cells and regulates osteoclast formation at the postnatal stage [@B7].

Recent lineage tracing studies revealed that cells expressing *Cre*-recombinases driven by the *Col2* promoter/enhancer and their descendants contributed to, in addition to chondrocytes, early perichondrial precursor cells [@B8]. Similarly, a recent study also demonstrated that hypertrophic chondrocytes can become an osteoblast and contribute to the osteogenic lineage cells [@B9]. In these studies, a cell-specific tamoxifen-inducible genetic recombination approach was utilized to track the fate of murine hypertrophic chondrocytes and the study showed that hypertrophic chondrocytes can survive the cartilage-to-bone transition and become osteogenic cells during embryonic and postnatal skeletal development and persist into adulthood [@B9]. These studies provide new insights into the function and signaling mechanisms in *Col2*- (or *Col10*-) expressing cells.

Using *Col2-CreER* transgenic mice to specifically delete *β-catenin* in *Col2*-expressing mesenchymal progenitor cells and chondrocytes, in the present studies we demonstrated that these *β-catenin^Col2CreER^* knockout (KO) mice display severe defects in epiphyseal bone, including increased osteoclast formation and accumulation of adipocytes in the marrow cavity. In addition, we also found adipocyte accumulation in the bone marrow underneath the growth plate. We also observed the destruction and bone loss in vertebral bone in *β*-*catenin^Col2CreER^* KO mice. Our studies provide additional evidence of β-catenin signaling in postnatal bone remodeling and bone homeostasis.

Materials and Methods
=====================

Animals
-------

*Col2-CreER^T2^* transgenic mice were generated in our lab [@B10]-[@B12] and *ROSA^mT/mG^* and *ROSA26R* reporter mice [@B13] were obtained from Jackson Laboratories (Bar Harbor, ME, USA). *β-catenin^flox^*^/*flox*^ mice were originally reported by Brault et al. [@B14] (obtained from Jackson lab) and we have used these mice in our previous studies [@B7]. *β-cat*enin*^Col2CreER^*mice were generated by breeding *β-catenin^flox^*^/*flox*^ mice with *Col2-CreER^T2^* transgenic mice. Tamoxifen (Sigma, St. Louis, MO, USA) was administered into 2-week-old *β-cat*enin*^Col2CreER^*and Cre-negative control mice by intraperitoneal (i.p.) injection (1 mg/l0 g body weight for 5 consecutive days) and mice were sacrificed when they are 3-month-old. The animal protocol of this study has been approved by the IACUC of the Rush University and all experimental methods and procedures were carried out in accordance with the approved guidelines.

Cre-Recombination Efficiency
----------------------------

*Col2-CreER^T2^*mice were bred with *ROSA^mT/mG^* and *ROSA26R* reporter mice to generate *Col2-CreER^T2^; ROSA^mT/mG^* and *Col2-CreER^T2^; ROSA26R* mice. Tamoxifen was administered into 2-week-old mice by i.p. injection (1 mg/l0 g body weight for 5 days). Long bones were dissected after the mice were sacrificed at 4-week-old, fixed in 0.2 % glutaraldehyde at 4°C for 2 days, followed by washing three times with phosphate buffered saline (PBS). Samples were decalcified in 14% EDTA for 3 weeks, cryo-protected in 30% sucrose at 4°C for 3 days, and then embedded and processed for frozen sections. Three μm thick sections were used for lacZ staining.

Micro-CT Analysis
-----------------

In 3-month-old *Col2-CreER^T2^*and Cre-negative control mice, quantitative μCT analysis was performed on a VivaCT 40 Scanner (Scanco Medical) at a resolution of 10 μm. Briefly, scanning in the femur/tibia began approximately at the proximal femur, and then extended proximally for 600 slices (10-μm thickness for each slice). Morphometric analysis was performed on 100 slices extending proximally. The 3-dimensional structure and morphometry were reconstructed and analyzed.

Histologic and Histomorphometric Analyses
-----------------------------------------

We dissected long bones from *β-cat*enin*^Col2CreER^*mice, and their corresponding Cre-negative control mice. Samples were fixed in 10% neutral buffered formalin (VWR, Radnor, PA, USA) for 3 days, decalcified with formic acid (Decal Chemical Corp., Suffern, NY, USA) for 14 days. Samples were processed and embedded in paraffin. Three μm thick mid-sagittal sections at 3 different levels (50 μm apart) were cut from the medial compartment of the long bone. The sections were stained with Safranin O/fast green (SO/FG), Alcian blue/H&E Orange G (AB/H&E-OG) and tartrate resistant acid phosphatase (TRAP) for morphologic analysis. Three slides per mouse, 6 mice per group, were analyzed in the experiment. Histomorphometric analysis was performed using the OsteoMeasure system (OsteoMetrics, Decatur, GA).

Bone Marrow Stromal Cell Culture
--------------------------------

Bone marrow stromal (BMS) cells were isolated from 3-month-old Cre-negative control and *β-catenin^Col2CreER^* KO mice or from 3-month-old *β-catenin^flox/flox^* mice which were infected with Ad-CMV-Cre or Ad-CMV-GFP (control virus), as described previously [@B15], [@B16]. The BMS cells were cultured with osteoblast differentiation medium for 3 days and β-catenin protein levels and mRNA expression of osteoblast marker genes, such as *Runx2*, *Col1a1*, *alkaline phosphatase* (*Alp*), *bone sialoprotein* (*BSP*) and *osteocalcin* (*OC*) was analyzed by real-time polymerase chain reaction (PCR) analysis. The cells were also cultured with adipocyte differentiation medium for 3 days and expression of adipocyte marker genes, such as PPAR-γ and cEBP-α, was also analyzed by real-time PCR analysis. Total RNA was prepared using a PureLink RNA Mini kit (Invitrogen) according to the manufacturer\'s protocol.

Statistical Analysis
--------------------

The values are presented as mean ± standard error. Statistical difference between groups was evaluated by Student\'s *t*-test with SPSS13.0 statistical software. \**P \<* 0.05 and \*\**P* \< 0.01 were considered as significant difference between groups.

Results
=======

High Cre-Recombination Efficiency of *Col2-CreER^T2^* mice to Target Articular Chondrocytes, Growth Plate Chondrocytes and Bone Marrow Cells below the Growth Plate
-------------------------------------------------------------------------------------------------------------------------------------------------------------------

To evaluate targeting efficiency of *Col2-CreER^T2^* mice in epiphyseal area, we first bred *Col2a1-CreER^T2^* mice with *ROSA^mT/mG^* reporter mice and generated *Col2-CreER^T2^; ROSA^mT/mG^*mice. Tamoxifen was administered when the mice were at 2-week-old and long bone samples were harvested at 4-week-old. Significant amounts of *Col2-CreER^T2^* targeting cells were detected in bone marrow stromal (BMS) cells below the growth plate (Fig. [1](#F1){ref-type="fig"}A, white arrowheads). We also bred *Col2a1-CreER^T2^* mice with *ROSA26R* reporter mice to generate *Col2-CreER^T2^; ROSA26R* mice. Similarly, tamoxifen was given to the mice at 2-week-old and bone samples were collected at 4-week-old. The results of lacZ staining revealed no recombination was found in growth plate and articular chondrocytes in Cre-negative mice (Fig. [1](#F1){ref-type="fig"}B, left panel). The blue-labelled chondrocytes in *Col2-CreER^T2^; ROSA26R* mice showed *Col2*-expressing cells in articular cartilage and growth plate cartilage (Fig. [1](#F1){ref-type="fig"}B, right panel). The role of β-catenin in epiphyseal bone was first investigated by X-ray radiographic analysis in *β-catenin^Col2CreER^*mice. Tamoxifen was given to 2-week-old mice and the mice were analyzed by X-ray at 3 months of age. The size of *β-catenin^Col2CreER^* KO mice was similar to Cre-negative control mice (data not shown), suggesting that β-catenin has no significant effect on bone growth at postnatal stage.

Specific Deletion of *β-Catenin* in *Col2*-Expressing Cells Leads to Defects of Epiphyseal Bone
-----------------------------------------------------------------------------------------------

Micro-CT analysis revealed significant bone loss and marked bone destruction in the epiphyseal area in 3-month-old *β-catenin^Col2CreER^* KO mice (Fig. [2](#F2){ref-type="fig"}A, yellow arrowheads). In comparison to Cre-negative control mice, bone volume (%, BV/TV) was significantly reduced in *β-catenin^Col2CreER^* KO mice (\**P* \< 0.05; n = 6) (Fig. [2](#F2){ref-type="fig"}B). Consistent results were also obtained when other bone structure parameters were analyzed by μCT. The connectivity density was significantly reduced (Fig. [2](#F2){ref-type="fig"}C) (\*\**P* \< 0.01; n = 6) and structural model index was significantly increased in *β-catenin^Col2CreER^* KO mice (\**P* \< 0.05; n = 6) (Fig. [2](#F2){ref-type="fig"}D).

Deletion of *β-Catenin* in *Col2*-Expressing Cells Leads to Increased Osteoclast and Adipocyte Formation
--------------------------------------------------------------------------------------------------------

To determine the mechanism of bone loss in epiphyseal area of *β-catenin^Col2CreER^* KO mice, we performed histological analysis using histology sections derived from 3-month-old *β-catenin^Col2CreER^* KO and Cre-negative control mice. Histological analysis of Safranin O/fast green (SO/FG) and Alcian/H&E Orange G (AB/HE-OG) stained sections showed a significant bone loss and accumulation of adipocytes in bone marrow, especially in the area below the growth plate (Fig. [3](#F3){ref-type="fig"}A and B). To determine changes in osteoclast formation, we performed TRAP staining and found that TRAP-positive osteoclast formation was significantly increased in *β-catenin^Col2CreER^* KO mice (Fig. [3](#F3){ref-type="fig"}C). Black arrowheads marked TRAP-positive osteoclasts and yellow arrowheads marked adipocytes. Consistent with the μCT findings, results of histomorphometric analysis also showed a significantly reduced bone volume and osteoblast numbers in *β-catenin^Col2CreER^* KO mice (Fig. [3](#F3){ref-type="fig"}D and E). In contrast, osteoclast numbers were significantly increased in *β-catenin^Col2CreER^* KO mice (Fig. [3](#F3){ref-type="fig"}F).

To further analyze adipocyte formation, we isolated BMS cells and cultured these cells in the presence of adipocyte differentiation medium. We found that more adipocytes were formed in cultured cells derived from *β-catenin^Col2CreER^* KO mice (Fig. [3](#F3){ref-type="fig"}G). Expression of PPAR-γ and cEBP-α, two adipocyte differentiation markers, was significantly increased in the cells derived from *β-catenin^Col2CreER^* KO mice (Fig. [3](#F3){ref-type="fig"}H). We then isolated BMS cells from *β-catenin^flox/flox^* mice and infected these cells with Ad-CMV-Cre. In the BMS cells with *β-catenin in vitro* deletion, β-catenin levels were very low and expression of PPAR**-**γ and cEBP**-**α was much higher in *β-catenin* deficient cells (Fig. [3](#F3){ref-type="fig"}I and J).

Deletion of *β-Catenin* in *Col2a1*-Expressing Cells Leads to Defects of Vertebrae
----------------------------------------------------------------------------------

In addition to long bone, we also analyzed changes in vertebral bone in *β-catenin^Col2CreER^* KO mice using μCT technique. Similar to the results found in epiphyseal bone, bone destruction and bone loss phenotype was found in L4-5 of vertebral bones of *β*-*catenin^Col2CreER^* KO mice (Fig. [4](#F4){ref-type="fig"}, right panel, red and yellow arrowheads).

Specific Deletion of *β-Catenin* in *Col2a1*-Expressing Cells Inhibited Osteoblast Differentiation
--------------------------------------------------------------------------------------------------

To determine if osteoblast differentiation is altered in *β-catenin^Col2CreER^* KO mice, we isolated BMS and examined ALP staining and expression of osteoblast marker genes. No significant changes in ALP activity and expression of osteoblast marker genes were found in *β*-*catenin^Col2CreER^* KO mice (data not shown). To further determine the effects of β-catenin in *Col2*-expressing cells, we isolated BMS cells from *β-catenin^flox/flox^* mice and infected these cells with Ad-CMV-Cre or Ad-CMV-GFP (control virus). We found that β-catenin protein levels were significantly decreased (Fig. [5](#F5){ref-type="fig"}A). Expression of osteoblast marker genes, including *Runx2*, *Col1a1*, *alkaline phosphatase* (*Alp*), *bone sialoprotein* (*BSP*) and *osteocalcin* (*OC*) was significantly decreased in *β-catenin* deficient BMS cells (Fig. [5](#F5){ref-type="fig"} B-F), suggesting that osteoblast differentiation was inhibited by deletion of β-catenin.

To summarize the effects of β-catenin in epiphyseal bone, we found that β-catenin inhibits osteoclast and adipocyte formation and promotes osteoblast differentiation (Fig. [6](#F6){ref-type="fig"}).

Discussion
==========

In this study, we generated *β-catenin^Col2CreER^* mouse model and demonstrated that deletion of *β-catenin* in *Col2*-expressing cells leads to severe defects in epiphyseal bone in *β*-*catenin^Col2CreER^* KO mice. Based on our studies and studies reported by other groups, the *Col2*-expressing cells not only include chondrocytes but also include mesenchymal progenitor cells [@B10]-[@B12], [@B8]. It has been reported that β-catenin plays a critical role in directing mesenchymal cell differentiation into different lineages of cells [@B3], [@B4]. Our previous [@B7] and current studies indicate that β-catenin promotes chondrocyte differentiation and inhibits adipocyte differentiation. Inhibition of β-catenin signaling in *Col2*-expressing progenitor cells leads to accumulation of adipocytes in bone marrow cavity. In addition, *Col2*-expressing progenitor cells could directly interact with osteoclast precursor cells. Inhibition of β-catenin signaling triggers osteoclast formation in epiphyseal area, suggesting that β-catenin in *Col2*-expressing cells plays a critical in regulation of osteoclast formation and is responsible for bone destruction under disease conditions.

Osteonecrosis is bone death caused by poor blood supply. It is most common in the hip and shoulder, but can affect other large joints such as the knee, elbow, wrist and ankle. After long period of lacking blood supply, the bone can collapse. If osteonecrosis is not treated, the joint deteriorates, leading to severe arthritis. Osteonecrosis can be caused by disease or by severe trauma, such as a fracture or dislocation that affects the blood supply to the bone. In osteonecrosis bone, increased osteoclast formation can be observed which leads to bone destruction [@B17]. However, administration of anti-bone resorption drugs, such as bisphosphonates, has also been shown often causing osteonerosis of the Jaw [@B18], [@B19]. Accumulation of adipocytes in subchondral area of epiphyseal bone is also observed in patients with osteonecrosis [@B20], [@B21]. Although the mechanism of β-catenin signaling in the pathogenesis of osteonecrosis has not been fully defined, it has already shown that activation of β-catenin signaling by Lithium chloride could relieve osteonecrosis of femoral head by promoting osteoblast differentiation and inhibiting adipocyte formation [@B22], [@B23].

In addition to the effects on long bone, *β-catenin* KO mice also showed severe defects in vertebral bone, suggesting that β-catenin also plays a role in vertebral bone remodeling. Our previous study indicates that *Col2*-expressing cells are mainly located in the inner annulus fibrosus cells and growth plate cartilage cells in the intervertebral disc tissue [@B24]. It is possible that *Col2*-expressing cells in growth plate cartilage area in disc tissues could migrate into the vertebral bone and transdifferentiate into osteoblast lineage cells, similar to the *Col2-*expressing cells in growth plate of long bone. The bone loss phenotype observed in vertebral bone may be due to the *β*-*catenin* deficiency in these cells.

In *β-catenin^Col2CreER^* KO mice, *Rankl* expression was increased and *Opg* expression was decreased in *Col2*-expressing cells [@B7]. β-catenin could directly act on *Opg* gene and regulate *Opg* transcription [@B6]. β-catenin also regulates *Rankl* expression through a glucocorticoid receptor (GR)-dependent mechanism [@B7]. Changes in osteoclast formation observed in the present studies could be due to the combination of up-regulation of RANKL and down-regulation of OPG [@B7].

In summary, our study demonstrates that inhibition of β-catenin signaling in *Col2*-expressing cells could lead to severe defects in long bone, especially in the epiphyseal region and in intervertebral disc, suggesting that β-catenin signaling plays an important role in bone remodeling and bone homeostasis at postnatal stage and in bone and joint diseases.
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![*Col2a1-CreER^T2^* mice efficiently target articular chondrocytes and growth plate chondrocytes and bone marrow stromal (BMS) cells near growth plate. *Col2a1-CreER^T2^* mice were bred with *ROSA^mTmG^* and *ROSA26R* reporter mice. Tamoxifen was given to 2-week-old mice. Analysis of fluorescence images and lacZ staining were performed in 4-week-old *Col2-CreER^T2^; ROSA^mTmG^* mice and*Col2-CreER^T2^; ROSA26R* mice. *Col2a1-CreER^T2^* targeting cells were detected in BMS cells underneath the growth plate (A, white arrowheads). LacZ-positive cells were also detected in articular chondrocytes (red arrowheads) and growth plate chondrocytes (yellow arrowheads) in *Col2-CreER^T2^; ROSA26R* mice.](ijbsv13p1540g001){#F1}

![Bone mass is reduced in *β-catenin^Col2CreER^* KO mice. (A) The μCT images displayed the bone loss in the epiphysis of distal femur and proximal tibia in 3-month-old *β-catenin^Col2CreER^* KO mice compared to Cre-negative control mice. Tamoxifen was given to 2-week-old mice. Bone loss and bone destruction appear in the epiphysis area (yellow arrowheads) but not the diaphysis area (green arrowheads) of long bone. (B-D) Bone volume (%, BV/TV), connectivity density and structural model index in the epiphysis of distal femur were analyzed by μCT. The quantification of these parameters showed significantly reduced bone volume (% BV/TV) and connectivity density and significantly increased structural model index. \**P* \< 0.05, \*\**P* \< 0.01, unpaired Student\'s *t*-test, n=6. Values are means ± SD.](ijbsv13p1540g002){#F2}

###### 

Adipocyte and osteoclast formation was increased in *β-catenin^Col2CreER^* KO mice. (A and B) Histologic analysis showed that significant bone loss and accumulation of adipocytes in bone marrow stromal (BMS) cells in 3-month-old *β-catenin^Col2CreER^* KO mice. (C) TRAP staining results showed that TRAP-positive osteoclasts (indicated by black arrowheads) and adipocytes (indicated by yellow arrowheads) were significantly increased in 3-month-old *β-catenin^Col2CreER^*KO mice. (D-F) Results of histomorphometric analysis showed that bone volume (%, BV/TV) and osteoblast numbers (N.Ob) were significantly reduced and osteoclast numbers (N.OC) was significantly increased in *β-catenin^Col2CreER^* KO mice. (G and H) We isolated BMS cells from 3-month-old *β-catenin^Col2CreER^* KO and Cre-negative mice and cultured these cells with adipocyte differentiation medium for 3 days. Results of Oil red O staining and expression of adipocyte marker genes, including PPAR**-**γ and cEBP**-**α, showed that adipocyte formation was increased in *β-catenin^Col2CreER^* KO mice. (I and J) We further isolated BMS cells from *β*-*catenin^flox/flox^* mice and infected these cells with Ad-CMV-Cre or Ad-CMV-GFP (control virus). β-catenin levels were significantly reduced and expression of adipocyte marker genes was significantly increased in *β-catenin* deficient BMS cells.
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![Bone structure and bone mass were altered in vertebrae of *β-catenin^Col2CreER^* KO mice. Tamoxifen was given to 2-week-old *β-catenin^Col2CreER^*and Cre-negative control mice. The μCT images showed significant bone loss (red and yellow arrowheads) in vertebrae (L4-5) of 3-month-old *β-catenin^Col2CreER^* KO mice.](ijbsv13p1540g005){#F4}

![Osteoblast differentiation in was inhibited in *β-catenin^Col2CreER^* KO mice. Bone marrow stromal (BMS) cells were isolated from 3-month-old *β-catenin^flox/flox^* mice. The cells were infected with Ad-Cre or Ad-GFP (control virus) and cultured for 3 days in the presence of osteoblast differentiation medium. β-catenin protein levels and mRNA expression of osteoblast marker genes, including *Runx2*, *type I collagen* (*Col1a1*), *alkaline phosphatase* (*Alp*), *bone sialoprotein* (*BSP*) and *osteocalcin* (*OC*) were analyzed. In *β-catenin* deficient BMS cells, expression of osteoblast marker genes was significantly decreased.](ijbsv13p1540g006){#F5}

![The diagram showed β-catenin in *Col2a1*-expressing cells inhibits osteoclast and adipocyte formation and promotes chondrocyte and osteoblast differentiation.](ijbsv13p1540g007){#F6}
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